OH2 Injection in Melanoma

PHASE3RecruitingINTERVENTIONAL
Enrollment

340

Participants

Timeline

Start Date

March 8, 2023

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2027

Conditions
Melanoma
Interventions
DRUG

OH2

Oncolytic Type 2 Herpes Simplex Virus

DRUG

Salvage chemotherapy or best supportive care

single or combined, including but not limited to dacarbazine, temozolomide, taxoid, or platinum

Trial Locations (30)

100010

RECRUITING

Peking University Cancer Hospital, Beijing

116000

NOT_YET_RECRUITING

The First Affiliated Hospital of Dalian Medical University, Dalian

NOT_YET_RECRUITING

Liaoning Cancer Hospital & Institute, Shenyang

130000

RECRUITING

Jilin Cancer Hospital, Changchun

NOT_YET_RECRUITING

The first hospital of Jilin University, Changchun

150000

NOT_YET_RECRUITING

The First Affiliated Hospital of Harbin Medical University, Harbin

200000

RECRUITING

Fudan University Shanghai Cancer Center, Shanghai

210000

RECRUITING

Nanjing Drum Tower Hospital, Nanjing

250000

NOT_YET_RECRUITING

The Affiliated Cancer Hospital of Shandong First Medical University, Jinan

261000

RECRUITING

Weifang People's Hospital, Weifang

300000

NOT_YET_RECRUITING

Tianjin Medical University Cancer Institute & Hospital, Tianjin

310000

RECRUITING

Cancer Hospital Of The University Of Chinese Academy Of Sciences Zhejiang Cancer Hospital, Hangzhou

NOT_YET_RECRUITING

Sir Run Run Shaw Hospital, Hangzhou

330000

NOT_YET_RECRUITING

The First Affiliated Hospital of Nanchang University, Nanchang

350000

RECRUITING

Fujian Cancer Hosptial, Fuzhou

400000

NOT_YET_RECRUITING

Chongqing University Cancer Hospital, Chongqing

410000

RECRUITING

Hunan Cancer Hospital, Changsha

430000

NOT_YET_RECRUITING

Hubei Cancer Hospital, Wuhan

NOT_YET_RECRUITING

Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan

450000

RECRUITING

The Third People's Hospital of Zhengzhou, Zhengzhou

510000

NOT_YET_RECRUITING

Dermatology Hospital of Southern Medical University, Guangzhou

NOT_YET_RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

530000

NOT_YET_RECRUITING

Guangxi Medical University Cancer Hospital, Nanning

570100

NOT_YET_RECRUITING

Hainan Cancer Hospital, Haikou

610000

RECRUITING

West China Hospital of Sichuan University, Chengdu

650000

NOT_YET_RECRUITING

Yunnan Cancer Hospital, Kunming

710000

NOT_YET_RECRUITING

The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an

830000

NOT_YET_RECRUITING

The Affiliated Cancer Hospital, Xinjiang Medical University, Ürümqi

050000

NOT_YET_RECRUITING

The Fourth Hospital of Hebei Medical University and Hebei Tumor Hospital, Shijiazhuang

030000

NOT_YET_RECRUITING

Shanxi Bethune Hospital, Taiyuan

All Listed Sponsors
lead

Binhui Biopharmaceutical Co., Ltd.

INDUSTRY